The Medical Letter on Drugs and Therapeutics
Lopinavir/Ritonavir: A Protease-inhibitor Combination
January 8, 2001 (Issue: 1095)Lopinavir/ritonavir is the first fixed-dose combination of protease inhibitors approved by the FDA for the treatment of HIV infection. It is being marketed for use with other drugs in adults and children more than six months old. Lopinavir is a new...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.